Glaxo approval

Click to follow
The Independent Online
Glaxo approval

GLAXO WELLCOME, the pharmaceutical giant, yesterday won US approval for its anti-Aids drug Ziagen.

The company said that it planned to launch the drug, also known as Abacavir, in January. Analysts have predicted that Ziagen, part of Glaxo's strong anti-Aids drug portfolio, could have sales of up to $840m.